Russian Study of the Effect of Continuous Positive Airway Pressure (CPAP) in Hypertension

NCT00801671 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2011-06-17

No results posted yet for this study

Summary

The purpose of this study is to determine whether CPAP is effective in the treatment of systemic hypertension.

Conditions

Interventions

PROCEDURE

cPAP

After reaching target level of BP patients will be randomized in active group (cPAP) and control group (sham-cPAP)

Sponsors & Collaborators

  • Russian Cardiology Research and Production Center

    lead OTHER

Principal Investigators

  • Alexandr Yu Litvin, MD · Russian Cardiology Research and Production Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2011-06-30
Completion
2011-06-30

Countries

  • Russia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00801671 on ClinicalTrials.gov